Matthew Herder
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 17, 2025
Flexibility over rigor: stakeholder acceptance of the limitations of confirmatory studies following accelerated approval.Holly Fernandez Lynch, Sejin Lee, Matthew Herder
|Sep 23, 2024
'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.Matthew Herder, Ximena Benavides
|May 31, 2024
"A Most Equitable Drug": How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development.Quinn Grundy, Chantal Campbell, Ridwaanah Ali
|Mar 13, 2024
Aducanumab, Accelerated Approvals & the Agency: Why the FDA Needs Structural Reform.Matthew Herder
|Aug 14, 2023
Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.Ipek Eren Vural, Matthew Herder, Agnieszka Doll
|Aug 04, 2022
On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data.Jessie Pappin, Itai Bavli, Matthew Herder
Pageof 1
